Acino has completed its acquisition of parts of Takeda’s primary care portfolio in selected countries in the Middle East, Africa and Ukraine.
Switzerland-based Acino has announced the completion of its acquisition of parts of Takeda’s primary care portfolio in key emerging markets in the Middle East, Africa and Ukraine.
“Acino has received antitrust approvals in Turkey, South Africa and Ukraine and can now proceed with the integration as planned,”...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
